Structure Therapeutics Inc.
GPCR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $170 | $130 | $26 | $105 |
| Short-Term Investments | $714 | $338 | $65 | $2 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $8 | $6 | $2 | $2 |
| Total Curr. Assets | $891 | $474 | $93 | $109 |
| Property Plant & Equip (Net) | $7 | $8 | $1 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $5 | $0 | $3 | $0 |
| Total NC Assets | $12 | $8 | $5 | $2 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $903 | $482 | $98 | $111 |
| Liabilities | – | – | – | – |
| Payables | $8 | $5 | $6 | $3 |
| Short-Term Debt | $2 | $1 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $26 | $18 | $7 | $5 |
| Total Curr. Liab. | $36 | $25 | $13 | $9 |
| LT Debt | $2 | $4 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $200 | $167 |
| Total NC Liab. | $2 | $4 | $200 | $167 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $4 | $5 | $0 | $1 |
| Total Liabilities | $38 | $29 | $213 | $176 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$329 | -$207 | -$117 | -$65 |
| AOCI | $1 | $1 | -$0 | $0 |
| Other Equity | $1,193 | $659 | $2 | $0 |
| Total Equity | $865 | $453 | -$115 | -$65 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $903 | $482 | $98 | $111 |
| Net Debt | -$166 | -$124 | -$26 | -$105 |